The effect of APOE-ɛ4 carrier status on longitudinal cognitive decline in PD was investigated in the CamPaIGN cohort (n = 107) over a 5-year period from diagnosis, and no evidence for association with rate of change in MMSE scores, age-dependent cognitive decline, or incidence of dementia was found (84). Here, APOE is linked to Mental deterioration.